These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3923911)

  • 1. Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccharides.
    Sadoff JC; Wright DC; Futrovsky S; Sidberry H; Collins H; Kaufmann B
    Antibiot Chemother (1971); 1985; 36():134-46. PubMed ID: 3923911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.
    Stoll BJ; Pollack M; Young LS; Koles N; Gascon R; Pier GB
    Infect Immun; 1986 Sep; 53(3):656-62. PubMed ID: 2427453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides.
    Pollack M; Tao M; Akiyama M; Pier GB; Koles NL
    Antibiot Chemother (1971); 1991; 44():163-71. PubMed ID: 1801635
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime.
    Akiyama M; Oishi K; Tao M; Matsumoto K; Pollack M
    Microbiol Immunol; 2000; 44(8):629-35. PubMed ID: 11021392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.
    Terashima M; Uezumi I; Tomio T; Kato M; Irie K; Okuda T; Yokota S; Noguchi H
    Infect Immun; 1991 Jan; 59(1):1-6. PubMed ID: 1898896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
    Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
    Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
    Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K
    J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against lipopolysaccharide protect against
    Kang J; Mateu-Borrás M; Monroe HL; Sen-Kilic E; Miller SJ; Dublin SR; Huckaby AB; Yang E; Pyles GM; Nunley MA; Chapman JA; Amin MS; Damron FH; Barbier M
    Front Cell Infect Microbiol; 2023; 13():1191806. PubMed ID: 37424774
    [No Abstract]   [Full Text] [Related]  

  • 13. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
    Lang AB; Fürer E; Schürch U; Cross AS; Larrick JW; Cryz SJ
    Dev Biol Stand; 1990; 71():121-6. PubMed ID: 1698165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable cross-reactivity of Pseudomonas aeruginosa lipopolysaccharide-code-specific monoclonal antibodies and its possible relationship with serotype.
    Yokota S; Terashima M; Chiba J; Noguchi H
    J Gen Microbiol; 1992 Feb; 138(2):289-96. PubMed ID: 1564440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently.
    Schreiber JR; Cooper LJ; Diehn S; Dahlhauser PA; Tosi MF; Glass DD; Patawaran M; Greenspan NS
    J Infect Dis; 1993 Jan; 167(1):221-6. PubMed ID: 8418172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polyreactive human anti-lipid A monoclonal antibody having cross reactivity to polysaccharide portions of Pseudomonas aeruginosa lipopolysaccharides.
    Yokota S; Ohtsuka H; Kohzuki T; Noguchi H
    FEMS Immunol Med Microbiol; 1996 May; 14(1):31-8. PubMed ID: 8804973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa.
    Schreiber JR; Patawaran M; Tosi M; Lennon J; Pier GB
    J Immunol; 1990 Feb; 144(3):1023-9. PubMed ID: 2104908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.
    Pier GB; Thomas D; Small G; Siadak A; Zweerink H
    Infect Immun; 1989 Jan; 57(1):174-9. PubMed ID: 2491835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa.
    Sawada S; Kawamura T; Masuho Y; Tomibe K
    J Infect Dis; 1985 Nov; 152(5):965-70. PubMed ID: 3930629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.